Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2031572
Max Phase: Preclinical
Molecular Formula: C20H15F2N5O2
Molecular Weight: 395.37
Molecule Type: Small molecule
Associated Items:
ID: ALA2031572
Max Phase: Preclinical
Molecular Formula: C20H15F2N5O2
Molecular Weight: 395.37
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(-n2c(=O)[nH]c3c(C(N)=O)nc(-c4ccc(F)cc4F)nc32)cc1C
Standard InChI: InChI=1S/C20H15F2N5O2/c1-9-3-5-12(7-10(9)2)27-19-16(25-20(27)29)15(17(23)28)24-18(26-19)13-6-4-11(21)8-14(13)22/h3-8H,1-2H3,(H2,23,28)(H,25,29)
Standard InChI Key: SRHZLNJYMTTXBN-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 395.37 | Molecular Weight (Monoisotopic): 395.1194 | AlogP: 2.77 | #Rotatable Bonds: 3 |
Polar Surface Area: 106.66 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.12 | CX Basic pKa: | CX LogP: 5.36 | CX LogD: 5.36 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.56 | Np Likeness Score: -1.86 |
1. Nagarajan S, Skoufias DA, Kozielski F, Pae AN.. (2012) Receptor-ligand interaction-based virtual screening for novel Eg5/kinesin spindle protein inhibitors., 55 (6): [PMID:22309208] [10.1021/jm201290v] |
Source(1):